Estimating the number of measles-susceptible children and adolescents in the United States using data from the National Immunization Survey-Teen (NIS-Teen)

American Journal of Epidemiology

Volumn 184, Issue 2, 2016, Pages 148-156

  Bednarczyk, Robert A ^a,b   Orenstein, Walter A ^b,c   Omer, Saad B ^a,b,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

disease susceptibility; immunization; measles; measles mumps rubella vaccine

Indexed keywords

MATERNAL ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

ADOLESCENCE; AGE STRUCTURE; ANTIBODY; CANCER; DISEASE TRANSMISSION; DISEASE TREATMENT; EPIDEMIOLOGY; ESTIMATION METHOD; IMMUNIZATION; MEASLES; VACCINATION;

ADOLESCENT; AGE SPECIFIC CARE; ARTICLE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; SENSITIVITY ANALYSIS; TUMOR IMMUNITY; UNITED STATES; VIRUS IMMUNITY; VIRUS TRANSMISSION; AGE DISTRIBUTION; HERD IMMUNITY; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; STANDARDS; STATISTICS AND NUMERICAL DATA;

UNITED STATES;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; HEALTH CARE SURVEYS; HUMANS; IMMUNITY, HERD; IMMUNIZATION PROGRAMS; INFANT; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; UNITED STATES;

EID: 84980317011     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv320     Document Type: Article

References (49)

1. Elam-Evans LD, Yankey D, Singleton JA, et al. National, state, and selected local area vaccination coverage among children aged 19-35 months-United States, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63(34): 741-748
2. Seither R, Masalovich S, Knighton CL, et al. Vaccination coverage among children in kindergarten-United States, 2013-14 school year. MMWR Morb Mortal Wkly Rep. 2014; 63(41): 913-920
3. Centers for Disease Control and Prevention. Measles cases and outbreaks. http://www.cdc.gov/measles/cases-outbreaks.html. Updated May 2, 2016. Accessed June 6, 2016
4. Strebel PM, Papania MJ, Parker Fiebelkorn A, et al. Measles vaccine. In. Plotkin S, Orenstein WA, Offit P, eds. Vaccines. 6th ed. Philadelphia, PA. Elsevier Saunders; 2013: 352-387
5. Centers for Disease Control and Prevention. Measles-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012; 61(15): 253-257
6. Gastañaduy PA, Redd SB, Fiebelkorn AP, et al. Measles- United States, January 1-May 23, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63(22): 496-499
7. Vega JS, Escobedo M, Schulte CR, et al. Notes from the field: measles transmission at a domestic terminal gate in an international airport-United States, January 2014. MMWR Morb Mortal Wkly Rep. 2014; 63(50): 1211
8. Hethcote HW.Measles and rubella in the United States. Am J Epidemiol. 1983; 117(1): 2-13
9. Centers for Disease Control and Prevention. Datasets and related documentation for the National Immunization Survey. http://www.cdc.gov/nchs/nis/data-files-Teen.htm. Updated March 26, 2015. Accessed June 6, 2016
10. National Center for Health Statistics. Live Births, Birth Rates, and Fertility Rates, by Race: United States, 1909-2003. Atlanta, GA. Centers for Disease Control and Prevention; 2013
11. Centers for Disease Control and Prevention. National vaccination coverage levels among children aged 19-35 months-United States, 1998. MMWR Morb Mortal Wkly Rep. 1999; 48(37): 829-830
12. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1997. MMWR Morb Mortal Wkly Rep. 1998; 47(26): 547-554
13. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1999. MMWR Morb Mortal Wkly Rep. 2000; 49(26): 585-589
14. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 2000. MMWR Morb Mortal Wkly Rep. 2001; 50(30): 637-641
15. Barker L, Luman E, Zhao Z, et al. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 2001. MMWR Morb Mortal Wkly Rep. 2002; 51(30): 664-666
16. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, January-December 1995. MMWR Morb Mortal Wkly Rep. 1997; 46(8): 176-182
17. Centers for Disease Control and Prevention. National, state, and urban area vaccination levels among children aged 19-35 months-United States
18. Centers for Disease Control and Prevention. National, state, and urban area vaccination levels among children aged 19-35 months-United States, 2002. MMWR Morb Mortal Wkly Rep. 2003; 52(31): 728-732
19. Centers for Disease Control and Prevention. State and national vaccination coverage levels among children aged 19-35 months-United States, April-December 1994. MMWR Morb Mortal Wkly Rep. 1995; 44(33): 613, 619, 621-623
20. Centers for Disease Control and Prevention. Status report on the Childhood Immunization Initiative: national, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1996. MMWR Morb Mortal Wkly Rep. 1997; 46(29): 657-664
21. McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013; 62(RR-04): 1-34
22. Leuridan E, Hens N, Hutse V, et al. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010; 340: c1626
23. Waaijenborg S, Hahné SJM, Mollema L, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013; 208(1): 10-16
24. Gans H, Yasukawa L, Rinki M, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis. 2001; 184(7): 817-826
25. McQuillan GM, Kruszon-Moran D, Hyde TB, et al. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis. 2007; 196(10): 1459-1464
26. Maldonado YA, Lawrence EC, DeHovitz R, et al. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics. 1995; 96(3): 447-450
27. Markowitz LE, Albrecht P, Rhodes P, et al. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics. 1996; 97(1): 53-58
28. Papania M, Baughman AL, Lee S, et al. Increased susceptibility to measles in infants in the United States. Pediatrics. 1999; 104(5): e59
29. Redd SC, King GE, Heath JL, et al. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. J Infect Dis. 2004; 189(suppl1): S116-S122
30. Zignol M, Peracchi M, Tridello G, et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004; 101(3): 635-641
31. Bochennek K, Allwinn R, Langer R, et al. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer. Vaccine. 2014; 32(27): 3357-3361
32. Special Section: Cancer in Children & Adolescents. In. American Cancer Society. Cancer Facts & Figures 2014, . Atlanta, GA. American Cancer Society; 2014: 25-42
33. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2012. MMWR Morb Mortal Wkly Rep. 2013; 62(36): 733-740
34. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis. 2004; 189(suppl 1): S43-S47
35. Strikas RA. Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years-United States, 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(4): 93-94
36. Perry RT, Halsey NA. The clinical significance of measles: a review.J Infect Dis. 2004; 189(suppl 1): S4-S16
37. Salmon DA, Haber M, Gangarosa EJ, et al. Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA. 1999; 282(1): 47-53
38. Glass K, Kappey K, Grenfell BT. The effect of heterogeneity in measles vaccination on population immunity. Epidemiol Infect. 2004; 132(4): 675-683
39. Schlenker TL, Bain C, Baughman AL, et al. Measles herd immunity. The association of attack rates with immunization rates in preschool children. JAMA. 1992; 267(6): 823-826
40. Grenfell BT, Anderson RM. The estimation of age-related rates of infection from case notifications and serological data. J Hyg (Lond). 1985; 95(2): 419-436
41. Fine P, Eames K, Heymann DL. "Herd immunity": a rough guide. Clin Infect Dis. 2011; 52(7): 911-916
42. Fine PEM, Mulholland K. Community immunity. In. Plotkin S, OrensteinWA, Offit P, eds. Vaccines. 6th ed. Philadelphia, PA. Elsevier Saunders; 2013: 1395-1412
43. Chen SY, Anderson S, Kutty PK, et al. Health care-Associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis. 2011; 203(11): 1517-1525
44. Coleman MS, Garbat-Welch L, Burke H, et al. Direct costs of a single case of refugee-imported measles in Kentucky. Vaccine. 2012; 30(2): 317-321
45. Ortega-Sanchez IR, Vijayaraghavan M, Barskey AE, et al. The economic burden of sixteen measles outbreaks on United States public health departments in 2011. Vaccine. 2014; 32(11): 1311-1317
46. Sugerman DE, Barskey AE, Delea MG, et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics. 2010; 125(4): 747-755
47. Lieu TA, Ray GT, Klein NP, et al. Geographic clusters in underimmunization and vaccine refusal. Pediatrics. 2015; 135(2): 280-289
48. Feikin DR, Lezotte DC, Hamman RF, et al. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA. 2000; 284(24): 3145-3150
49. Organ Procurement and Transplantation Network. View data reports. https://optn.transplant.hrsa.gov/data/view-data-reports/. Published 2015. Accessed June 6